Make It Work!: Fitting Trademark Law into the World of Metaverse Fashion

As the fashion world winds down from a season of fashion weeks in New York, Milan, Paris, and Los Angeles, buzz around new designs and creators is at a high. People are reflecting on what ensembles graced the catwalk and studying which ones garnered a nod from Anna Wintour. If you sadly didn’t receive an invite to a show, never fear, because the looks are certainly gracing the internet.
Continue reading “Make It Work!: Fitting Trademark Law into the World of Metaverse Fashion”

The Trademark Tales of San Diego Comic-Con

$160 million in revenue. 167,000 attendees. 1,000+ exhibitors and panels. One location.

These are just some of the statistics of the San Diego Comic Convention, the world’s most well-known comic book and pop culture convention, over the past decade. This convention also goes by several names, including Comic-Con International: San Diego, San Diego Comic-Con, and SDCC.

Continue reading “The Trademark Tales of San Diego Comic-Con”

Killer Trademarks


Knew He Was a Killer, First Time that I Saw Him

Eight Pro Bowls. Four First-Team All-Pro Awards. Three Second-Team All-Pro Awards. Two Super-Bowl Championships. One Podcast. We know all too well that Travis Kelce is one of the most accomplished football players in the NFL. From his accomplishments on field to his recent endeavors off-field like his podcast, New Heights, Travis Kelce has accomplished a lot in his first 34 years of life. But what’s gotten him to this level of recognition?

Continue reading “Killer Trademarks”

Tracks to Trademarks

Better read fast because as Ricky Bobby once said, ‘If you ain’t first, you’re last.’

If you breathed the same air as me this summer, you probably know I became a huge NASCAR fan. After hearing the first car roar on Michigan Avenue (even before walking into the Chicago Street Race), NASCAR earned my allegiance. So lucky you, you get to read about it too, haha! However, this time, with a recently acquired trademark lens.
Continue reading “Tracks to Trademarks”

Airplane against sunset

Still Calculating: Exploring IP as a WeekendJD Student at Loyola

I often hear this question: “But what are you going to do after law school?”

Right now, it’s an unsolved equation. But I’m working through the terms.

Patent Law = Engineering + Law

I’m exploring patent law because it represents the sum of two important interests in my life, engineering and law.
Continue reading “Still Calculating: Exploring IP as a WeekendJD Student at Loyola”

The Name Game

So you have a great idea for a new business and have thought of the perfect name.  But what if it turns out there’s a company who has already been using the same (or a similar) name to the one you’re planning on?  Or perhaps you’ve registered a domain name that happens to be similar to another’s?

The good news is this isn’t necessarily a cause to change the name you loved.  The bad news is there are a couple of claims that could be made against you depending on your circumstances.

Continue reading “The Name Game”

From Lululemon to Loyola: Finding My Way to IP

My first experience with Intellectual Property (IP) was in a business law class that I took during my senior year of undergrad. We had new units every week, and I was introduced to the topics of trademarks, copyrights, and patents as they relate to businesses. These turned out to be my favorite units from the semester because I loved learning about the ways businesses use IP to protect their ideas and make money off them. I didn’t realize that brand names, logos, and even the way individual products are designed could all be protected by IP law. I really enjoyed learning about how IP intersects with a business’s ability to build their brand recognition.

Continue reading “From Lululemon to Loyola: Finding My Way to IP”

The Price Isn’t Right: Sen. Warren’s Antidote to Costly Medicine

When I tell you the cost of many medications in America is prohibitively expensive, you likely aren’t surprised. Access to medicine and drug costs has been a major topic of debate for a long time. Most recently, U.S. politicians and pharma industry leaders have stoked the fiery debate on healthcare costs in response to the National Institute of Health’s (NIH) rejection for a petition to grant march-in rights for a prostate cancer medication called, Xtandi®. To learn more about march-in rights and the recent concern over the drug, Xtandi®, read High Drug Prices: Meet Bayh-Dole.
Continue reading “The Price Isn’t Right: Sen. Warren’s Antidote to Costly Medicine”